Steven Fasman - Catalent President

President

Mr. Steven L. Fasman is Senior Vice President, General Counsel and Corporationrationrate Secretary of the Company. Mr. Fasman was named Senior Vice President, General Counsel, and Corporationrationrate Secretary in October 2014, when he joined us. Prior to that, he served as Executive Vice PresidentLaw of MacAndrews Forbes Holdings Inc., a privately held diversified holding company, from January 2012 to March 2014. Before that, Mr. Fasman held various positions at MacAndrews Forbes since 1992 of increasing responsibility. From 2008 through March 2014, he also served as General Counsel and Chief Compliance Officer of M F Worldwide Corporationration, a holding company with interests in financial products, customer calling centers, staffing operations, educational software and flavoring products. From 2008 to 2011, Mr. Fasman also served as a director of SIGA Technologies, Inc., a biodefense company. Mr. Fasman spent his early career at the law firm of Paul, Weiss, Rifkind, Wharton Garrison, where he focused on domestic and international litigation and regulatory proceedings. Mr. Fasman holds a law degree from Yale University and an A.B. degree in mathematics from Princeton University. Mr. Fasman is a trustee of the Jewish Board of Family Childrens Services in New York City. since 2014.
Age 57
Tenure 11 years
Phone732 537 6200
Webhttps://www.catalent.com
Fasman holds a law degree from Yale University and a B.A. degree in mathematics from Princeton University.

Catalent Management Efficiency

Catalent's management efficiency ratios could be used to measure how well Catalent manages its routine affairs as well as how well it operates its assets and liabilities.
Catalent currently holds 4.92 B in liabilities with Debt to Equity (D/E) ratio of 0.9, which is about average as compared to similar companies. Catalent has a current ratio of 2.8, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Catalent's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

David SmithCharles River Laboratories
58
Roger GrahamTeleflex Incorporated
N/A
Eric SherbetIQVIA Holdings
60
Joseph LaPlumeCharles River Laboratories
50
Michael KnellCharles River Laboratories
48
Wendy StewartIQVIA Holdings
N/A
Matthew JamesTeleflex Incorporated
N/A
Timothy ErnstBio Rad Laboratories
64
Bhavik PatelIQVIA Holdings
45
Kevin KnightlyIQVIA Holdings
63
William BarboCharles River Laboratories
64
Karen BoylanTeleflex Incorporated
47
John DerenTeleflex Incorporated
N/A
Cameron HicksTeleflex Incorporated
60
Giovanni MagniBio Rad Laboratories
63
Birgit GirshickCharles River Laboratories
55
Praneet MehrotraTeleflex Incorporated
N/A
Christopher RyanWest Pharmaceutical Services
63
Ronald BruehlmanIQVIA Holdings
64
James LeydenTeleflex Incorporated
52
Cynthia VerstIQVIA Holdings
N/A
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey. Catalent operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 19000 people. Catalent (CTLT) is traded on New York Stock Exchange in USA and employs 17,000 people.

Management Performance

Catalent Leadership Team

Elected by the shareholders, the Catalent's board of directors comprises two types of representatives: Catalent inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Catalent. The board's role is to monitor Catalent's management team and ensure that shareholders' interests are well served. Catalent's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Catalent's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Castellano, VP of Fin. and Investor Relations and Treasurer
Paul Surdez, Vice Relations
Joseph JD, General VP
Tom PEng, President Delivery
Trish Hunt, President Health
Peter Zippelius, Independent Director
David McErlane, Group Segment
Steven Fasman, Senior Vice President General Counsel and Corporate Secretary
Michael Hatzfeld, VP Officer
Kay Schmidt, Senior Vice President - Technical Operations
Karen Santiago, VP Office
Jonathan Arnold, President - Oral & Specialty Delivery
Ricky Hopson, Division President
John MBA, Executive Board
John Chiminski, Chairman of the Board, Chief Executive Officer
Donald Morel, Independent Director
John Greisch, Independent Director
Gregory Lucier, Independent Director
Rolf Classon, Independent Director
Michael Barber, Independent Director
Steven Esq, Corp VP
Karen Flynn, President - Biologics and Chief Commercial Officer
Michael Grippo, Senior Vice President - Strategy and Corporate Development
Matti Masanovich, Senior CFO
Julien Meissonnier, VP Officer
Christa Kreuzburg, Independent Director
Lisa Evoli, Senior Officer
Madhavan Balachandran, Independent Director
J Carroll, Independent Director
Scott Gunther, Senior Vice President - Quality & Regulatory Affairs
Wetteny Joseph, Chief Financial Officer, Senior Vice President
Alessandro Maselli, Senior Vice President - Global Operations
Dejan Lamesic, Head Development
Ricci Whitlow, President - Clinical Supply Services
Charles Lickfold, Senior Vice President, Chief Information Officer
Aristippos Gennadios, President - Softgel & Oral Technologies
Ricardo Pravda, Chief Human Resource Officer, Senior Vice President
Jack Stahl, Lead Independent Director
Z Mahdavi, Vice President of Open Innovation, Biologics, Cell and Gene Therapy
Rosemary Crane, Independent Director

Catalent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Catalent a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Catalent Stock

If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account